z-logo
open-access-imgOpen Access
Abemaciclib (Verzenio)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.475
Subject(s) - medicine , breast cancer , oncology , endocrine system , human epidermal growth factor receptor 2 , adjuvant , estrogen receptor , adjuvant therapy , biomarker , cancer , hormone receptor , hormone therapy , gynecology , hormone , biology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here